TWI766640B - Evaluation method and detection device for blood glucose concentration - Google Patents
Evaluation method and detection device for blood glucose concentration Download PDFInfo
- Publication number
- TWI766640B TWI766640B TW110112767A TW110112767A TWI766640B TW I766640 B TWI766640 B TW I766640B TW 110112767 A TW110112767 A TW 110112767A TW 110112767 A TW110112767 A TW 110112767A TW I766640 B TWI766640 B TW I766640B
- Authority
- TW
- Taiwan
- Prior art keywords
- expiratory
- time
- gas
- blood glucose
- user
- Prior art date
Links
Images
Abstract
一種血糖濃度的評估方法,供使用者以非侵入性的方式進行量測,包含呼氣擷取量測步驟,及血糖評估步驟。該呼氣擷取量測步驟是擷取該使用者於一連續時間區間內呼出的一呼氣氣體的末段呼氣量,該末段呼氣量不大於該呼氣氣體的總呼氣量的10%,並量測該末段呼氣流量的二氧化碳濃度,以推估該使用者的血糖濃度。接著,該血糖評估步驟通過自該呼氣氣體中擷取之末段呼氣的二氧化碳濃度來進行血糖評估,而能排除該呼氣氣體中無效腔氣體的干擾,進而提升評估的準確性。此外,本發明還提供一用以進行前述之評估方法的檢測裝置。A method for evaluating blood glucose concentration for users to measure in a non-invasive manner, including the steps of breath capture and measurement, and the steps of blood glucose evaluation. The expiratory capture and measurement step is to capture the final expiratory volume of an expiratory gas exhaled by the user in a continuous time interval, and the final expiratory volume is not greater than the total expiratory volume of the expiratory gas 10%, and measure the carbon dioxide concentration of the end expiratory flow to estimate the user's blood sugar concentration. Next, in the blood glucose assessment step, blood glucose assessment is performed by using the carbon dioxide concentration in the final exhalation extracted from the expiratory gas, so that the interference of dead space gas in the expiratory gas can be excluded, thereby improving the accuracy of the assessment. In addition, the present invention also provides a detection device for carrying out the aforementioned evaluation method.
Description
本發明是有關於一種血糖濃度的評估方法及檢測裝置,特別是指一種非侵入性之血糖濃度的評估方法及檢測裝置。 The present invention relates to an evaluation method and a detection device for blood glucose concentration, in particular to a non-invasive evaluation method and detection device for blood glucose concentration.
呼吸時,呼吸的氣體會在肺泡中與血液進行呼吸交換,因此人所呼出的氣體會與自身血液中的成分具有一定程度的相關性。目前而言,在檢驗醫學上經常透過對受試者的呼氣氣體進行特定氣體分析,用以檢驗該受試者是否患有例如肺病、氣喘或肝臟問題等相關疾病,並以此評估該受試者的健康狀況,以利後續進行疾病治療與管理。其中,由於呼氣氣體中的二氧化碳(CO2)濃度與血糖濃度成正相關,因此,通過測量該受試者呼出氣體中的二氧化碳濃度,可進一步推知該受試者的血糖濃度情況,並可以此判斷該受試者是否有血糖代謝、糖尿病等相關疾病。日本發明專利第JP6352188B2核准公告號即揭示了一種測定糖代謝能力的方法,經由讓測試者服用標記有同位素C的葡萄糖後,在不同的時間點分次測量該測試者呼出氣體中的二氧化碳濃度,並觀察其中標記有同 位素C的二氧化碳佔整體二氧化碳氣體的含量,以此評估該測試者糖代謝的能力。 When breathing, the breathed gas will be exchanged with the blood in the alveoli, so the gas exhaled by a person will have a certain degree of correlation with the components in the blood. At present, in laboratory medicine, specific gas analysis is often performed on the exhaled gas of the subject to test whether the subject suffers from related diseases such as lung disease, asthma or liver problems, and thus to evaluate the subject. The health status of the subjects in order to facilitate the subsequent treatment and management of the disease. Among them, since the carbon dioxide (CO 2 ) concentration in the exhaled gas is positively correlated with the blood glucose concentration, by measuring the carbon dioxide concentration in the exhaled gas of the subject, the blood glucose concentration of the subject can be further inferred, and this Determine whether the subject has blood sugar metabolism, diabetes and other related diseases. Japanese Invention Patent No. JP6352188B2 Approval Announcement No. JP6352188B2 discloses a method for determining the ability of glucose metabolism. After the tester takes glucose labeled with isotope C, the carbon dioxide concentration in the exhaled breath of the tester is measured at different time points. And observe the content of carbon dioxide marked with isotope C in the total carbon dioxide gas to evaluate the ability of the tester to metabolize sugar.
基於非侵入性的檢測方法及檢測流程的便利性,前述利用量測呼氣氣體的方式來評估血糖已被相關領域廣為研究,然而,因為呼吸過程呼出的氣體中除了在肺泡進行呼吸交換的氣體外,還包含了來自口腔、呼吸道及支氣管的氣體,此類的氣體在醫學上被稱為無效腔(dead space)氣體,並不參與在肺泡中呼吸氣體與血液間的交換,因此該無效腔氣體的存在會令通過二氧化碳濃度來判斷血糖濃度的檢測方式產生誤差,並造成評估患者之血糖濃度或糖尿病等疾病的精確度不足。 Based on the convenience of non-invasive detection methods and detection procedures, the aforementioned method of measuring exhaled gas to assess blood glucose has been widely studied in related fields. In addition to the gas, it also includes the gas from the oral cavity, respiratory tract and bronchi. Such gas is called dead space gas in medicine, and does not participate in the exchange between breathing gas and blood in the alveoli, so it is invalid. The presence of the cavity gas will cause errors in the detection method of judging the blood glucose concentration by the carbon dioxide concentration, and cause insufficient accuracy in evaluating the blood glucose concentration of a patient or diseases such as diabetes.
因此,本發明的目的,即在提供一種血糖濃度的評估方法,以提高血糖濃度評估的精準度。 Therefore, the purpose of the present invention is to provide a method for evaluating blood glucose concentration, so as to improve the accuracy of evaluating blood glucose concentration.
於是,本發明血糖濃度的評估方法,供一使用者以非侵入性方式評估血糖狀況,包含一呼氣擷取量測步驟,及一血糖評估步驟。 Therefore, the method for evaluating the blood glucose concentration of the present invention, for a user to evaluate the blood glucose condition in a non-invasive manner, includes a breath capture measurement step and a blood glucose evaluation step.
該呼氣擷取量測步驟是擷取該使用者於一連續時間區間T0~Tn呼出的一呼氣氣體的末段呼氣量,並量測該末段呼氣量的二氧化碳濃度,其中,T0為一呼氣起始時間,Tn為一呼氣結束時間,該末段呼氣量擷取自介於一起始擷取時間TX1及一結束擷取時間 TX2間的時間區間,且T0<TX1,TX1<TX2≦Tn,X1、X2、n為自然數,且該末段呼氣量不大於該連續時間區間T0~Tn的總呼氣量的10%。 The breath capturing and measuring step is to capture a final expiratory volume of an expiratory gas exhaled by the user in a continuous time interval T 0 ~T n , and measure the carbon dioxide concentration of the final expiratory volume, Among them, T 0 is an expiratory start time, T n is an expiratory end time, and the final expiratory volume is captured from the time between an initial capture time T X1 and an end capture time T X2 interval, and T 0 <T X1 , T X1 <T X2 ≦T n , X1, X2, and n are natural numbers, and the final expiratory volume is not greater than the total expiratory volume in the continuous time interval T 0 ~T n 10%.
該血糖評估步驟是利用該末段呼氣量的二氧化碳濃度計算推估該使用者的血糖濃度,以得到血糖評估結果。 The blood glucose assessment step is to calculate and estimate the blood glucose concentration of the user by using the carbon dioxide concentration of the final expiratory volume to obtain a blood glucose assessment result.
本發明的另一目的,即在提供一種檢測裝置,適用於以非侵入性的方式進行二氧化碳濃度量測,以得到血糖評估結果。 Another object of the present invention is to provide a detection device suitable for measuring carbon dioxide concentration in a non-invasive manner to obtain blood glucose assessment results.
於是,本發明檢測裝置,供一使用者以非侵入性方式檢測血糖濃度,包含一氣體截留單元、一轉換單元、一感測單元,及一分析單元。 Therefore, the detection device of the present invention, for a user to detect the blood glucose concentration in a non-invasive manner, includes a gas trapping unit, a converting unit, a sensing unit, and an analyzing unit.
該氣體截留單元包括一中空管體,該中空管體具有一供接收該使用者呼出的呼氣氣體的進氣口,及一遠離該進氣口並用於將該呼氣氣體排出的排氣口。 The gas trapping unit includes a hollow tube body with an air inlet for receiving the exhaled gas exhaled by the user, and a discharge port away from the air inlet for discharging the exhaled gas breath.
該轉換單元包括一聲頻轉換器,該聲頻轉換器設置於該中空管體內並與該進氣口連通,自該進氣口導入的呼氣氣體可同時進入該聲頻轉換器,該聲頻轉換器可將不同時間進入的該呼氣氣體依據氣體量轉換成不同的聲波訊號。 The conversion unit includes an audio frequency converter, the audio frequency converter is arranged in the hollow tube body and communicated with the air inlet, the exhalation gas introduced from the air inlet can enter the audio frequency converter at the same time, the audio frequency converter The exhaled gas entering at different times can be converted into different sound wave signals according to the gas volume.
該感測單元設置於該中空管體內,並包括至少一供感測該呼氣氣體中的二氧化碳濃度的氣體感測器。 The sensing unit is disposed in the hollow tube and includes at least one gas sensor for sensing the carbon dioxide concentration in the exhaled gas.
該分析單元分別與該感測單元及該轉換單元訊號連接, 利用不同時間取得的該聲波訊號計算得到該呼氣氣體的一依時氣體量訊號,並可利用該依時氣體量訊號的結果取得該感測單元於一特定時間區段量測而得的二氧化碳濃度。 The analysis unit is respectively connected with the sensing unit and the conversion unit signal, A time-dependent gas volume signal of the expiratory gas can be calculated by using the acoustic wave signals obtained at different times, and the carbon dioxide measured by the sensing unit in a specific time period can be obtained by using the result of the time-dependent gas volume signal concentration.
本發明的功效在於:通過該呼氣擷取步驟自該呼氣氣體中擷取出該末段呼氣量,以排除來自口腔、呼吸道或支氣管等之無效腔氣體的干擾,而可僅依據所測得的該末段呼氣的二氧化碳濃度來進行血糖評估,進而提升評估的準確性。 The effect of the present invention is that: the final expiratory volume is extracted from the expiratory gas through the exhalation extraction step, so as to eliminate the interference of dead space gas from the oral cavity, respiratory tract or bronchus, etc., and can only be based on the measured The obtained carbon dioxide concentration at the end of exhalation can be used to evaluate blood glucose, thereby improving the accuracy of the evaluation.
200:檢測裝置 200: Detection device
2:氣體截留單元 2: Gas trapping unit
21:中空管體 21: Hollow body
211:進氣口 211: Air intake
212:排氣口 212: exhaust port
22:排氣件 22: Exhaust parts
3:轉換單元 3: Conversion unit
31:聲頻轉換器 31: Audio Converter
32:接收器 32: Receiver
4:感測單元 4: Sensing unit
41:氣體感測器 41: Gas sensor
5:分析單元 5: Analysis unit
60:預評估步驟 60: Pre-assessment step
61:呼氣擷取量測步驟 61: Exhalation capture measurement steps
62:血糖評估步驟 62: Blood Glucose Assessment Steps
本發明的其他的特徵及功效,將於參照圖式的實施方式中清楚地呈現,其中:圖1是一示意圖,說明本發明檢測裝置的一實施例;圖2是一流程圖,說明本發明血糖濃度的評估方法的一第一實施例;圖3是一呼氣之二氧化碳濃度與血糖濃度值的關係圖,說明該第一實施例測得之該使用者呼氣氣體中二氧化碳濃度與自身的血糖濃度的關係;及圖4是一流程圖,說明本發明血糖濃度的評估方法的一第二實施例。 Other features and effects of the present invention will be clearly presented in the embodiments with reference to the drawings, wherein: FIG. 1 is a schematic diagram illustrating an embodiment of the detection device of the present invention; FIG. 2 is a flow chart illustrating the present invention A first embodiment of a method for evaluating blood glucose concentration; FIG. 3 is a graph showing the relationship between the exhaled carbon dioxide concentration and the blood glucose concentration value, illustrating the relationship between the carbon dioxide concentration in the user's exhaled air measured by the first embodiment and its own relationship of blood glucose concentration; and FIG. 4 is a flowchart illustrating a second embodiment of the method for evaluating blood glucose concentration of the present invention.
在本發明被詳細描述前,應當注意在以下的說明內容中,類似的元件是以相同的編號來表示。 Before the present invention is described in detail, it should be noted that in the following description, similar elements are designated by the same reference numerals.
參閱圖1,本發明血糖濃度的評估方法是可透過一非侵入性的檢測裝置200以供使用者以非侵入性方式評估血糖濃度。
Referring to FIG. 1 , the method for evaluating the blood glucose concentration of the present invention can use a
該檢測裝置200包含一氣體截留單元2、一轉換單元3、一感測單元4,及一分析單元5。
The
該氣體截留單元2包括一中空管體21,及一排氣件22,該中空管體21具有一供接收該使用者呼出的呼氣氣體的進氣口211,及一遠離該進氣口211用於將該呼氣氣體排出的排氣口212。該排氣件22與該排氣口212連通,用於將進入該中空管體21的呼氣氣體強制向外排出。通過該排氣件22控制排出氣體的流速,令該中空管體21中在檢測的過程中維持氣體流通的狀態,使該呼氣氣體在呼氣過程中依時間自該排氣口212排出以避免氣體累積,而可用於控制僅保留特定時間區間的呼氣氣體於該中空管體21中。在本實施例中,該排氣件22是以一設置於該排氣口212處的風扇為例,但並不以此為限。
The
該轉換單元3包括一聲頻轉換器31,及一接收器32,該聲頻轉換器31設置於該中空管體21內並與該進氣口211連通,自該進氣口211導入的呼氣氣體可同時進入該聲頻轉換器31,該聲頻轉
換器31可依據不同時間吹入的氣體量大小,而將該呼氣氣體轉換成不同的聲波訊號;該接收器32鄰近該聲頻轉換器31設置,用於接收該等聲波訊號,可用於接收並放大該等聲波訊號。該聲頻轉換器31可選自哨音發音器。在本實施例中,是以該聲頻轉換器31為一哨音發音器、該接收器32為一麥克風為例,但並不以此為限。
The
該感測單元4設置於該中空管體21內,並包括至少一供感測該呼氣氣體中的二氧化碳濃度的氣體感測器41。在本實施例中,該感測單元4是以具有一個用來測量二氧化碳濃度的氣體感測器41,且該氣體感測器41設置於該中空管體內鄰近於該排氣口212的位置為例說明,然,實際實施時,該氣體感測器41的數量、設置位置並不以前述之實施態樣為限。
The
在一些實施例中,該感測單元4可具有兩個分別用以測量該呼氣氣體中的二氧化碳濃度及氧氣濃度的氣體感測器41,以同時量測取得該呼氣氣體的二氧化碳濃度,及氧氣濃度。
In some embodiments, the
該分析單元5分別與該感測單元4及該轉換單元3訊號連接,可接收該感測單元4於不同時間的二氧化碳濃度感測結果,而得到一依時濃度訊號;該分析單元5利用接收該轉換單元3自不同時間取得的該等聲波訊號計算得到該呼氣氣體的一依時氣體量訊號,並可利用該依時氣體量訊號計算求得該總呼氣量、末段呼氣量,及對應該末段呼氣量的末段呼氣時間區間,以進一步取得該感
測單元4於對應該末段呼氣時間區間量測而得的二氧化碳濃度。詳細的說,該分析單元5是通過該依時氣體量訊號與時間的積分計算,取得該呼氣氣體的總呼氣量,再經由總呼氣量計算得到末段呼氣量,並對應取得該末段呼氣量的量測時間區間,之後,藉由比對該二氧化碳的該依時濃度訊號,即可得到該末段呼氣量的量測時間區間內之呼氣氣體的二氧化碳濃度。
The
參閱圖1與圖2,本發明血糖濃度的評估方法的一第一實施例,供該使用者利用前述的該檢測裝置200進行呼氣氣體的二氧化碳濃度檢測,並可以此對應評估自身的血糖濃度。該第一實施例包含一呼氣擷取量測步驟61,及一血糖評估步驟62。
Referring to FIGS. 1 and 2 , a first embodiment of the method for evaluating blood glucose concentration of the present invention is for the user to use the
該呼氣擷取量測步驟61是擷取該使用者於一連續時間區間T0~Tn呼出的該呼氣氣體的末段呼氣量,並量測取得該末段呼氣量的二氧化碳濃度。其中,T0為一呼氣起始時間,Tn為一呼氣結束時間,n為自然數,該末段呼氣量擷取自一末段呼氣時間區間,該末段呼氣時間區間是介於一起始擷取時間TX1及一結束擷取時間TX2,T0<TX1,TX1<TX2≦Tn,X1、X2、n為自然數,且該末段呼氣量不大於該連續時間區間T0~Tn的總呼氣量的10%。也就是說,該末段呼氣量是擷取自呼氣結束時間前的一時間區間(即該末段呼氣時間區間)的呼氣量。
The breath capture and
該血糖評估步驟62是利用該末段呼氣量的二氧化碳濃度
計算推估該使用者的血糖濃度。
The blood
更詳細的說,該呼氣擷取量測步驟61是令該使用者自該中空管體21的進氣口211進行呼氣,讓該呼氣氣體經由該進氣口211、該聲頻轉換器31導入該中空管體21中。該感測單元4可持續地感測進入該中空管體21的呼氣氣體中的二氧化碳濃度而得到對應該連續時間區間T0~Tn的二氧化碳依時濃度變化結果。同時,進入該中空管體21的呼氣氣體可藉由該聲頻轉換器31產生具有不同強度、頻率的聲波訊號,而因為不同頻率、強度的聲波訊號會對應不同的氣體量,因此,可通過該分析單元5將該等聲波訊號轉換成該依時氣體量訊號,並利用該依時氣體量訊號與時間的積分計算,即可取得對應該連續時間區間T0~Tn的呼氣氣體的總呼氣量及/或特定時間區段內的氣體量(相當於該呼氣氣體的依時氣體量),接著,即可利用該總呼氣量計算得到該末段呼氣量,並據以定義出該末段呼氣時間區間的起始擷取時間TX1與該結束擷取時間TX2。之後,即可利用該二氧化碳依時濃度變化結果,取得該使用者於該末段呼氣時間區間之呼出氣體的二氧化碳濃度。
More specifically, the breath capture and
最後,即可利用該末段呼氣時間區間的二氧化碳濃度(平均值)與一血糖值標準值進行比對,而得到血糖評估結果。例如,以該使用者呼氣後計算得到的總呼氣量為2L,則該使用者的末段呼氣量為不大於200ml(不大於總呼氣量的10%),因此,透過該依時 氣體量訊號可得到該末段呼氣量對應的起始擷取時間TX1與該結束擷取時間TX2。再利用該起始擷取時間TX1與該結束擷取時間TX2與二氧化碳的依時濃度變化結果比對,即可得到該使用者的該末段呼氣時間區間的二氧化碳濃度,最後,即可透過二氧化碳濃度結果與相應的標準血糖濃度值進行比對,而得到血糖評估結果。 Finally, the carbon dioxide concentration (average value) in the final expiratory time interval can be used to compare with a standard value of blood glucose level to obtain the blood glucose evaluation result. For example, if the total expiratory volume calculated by the user after exhalation is 2L, the final expiratory volume of the user is not more than 200ml (not more than 10% of the total expiratory volume). From the time gas volume signal, the start capture time T X1 and the end capture time T X2 corresponding to the final expiratory volume can be obtained. Then, the carbon dioxide concentration in the last exhalation time interval of the user can be obtained by comparing the initial capture time T X1 and the end capture time T X2 with the time-dependent concentration change results of carbon dioxide. The blood glucose assessment result can be obtained by comparing the carbon dioxide concentration result with the corresponding standard blood glucose concentration value.
由於利用量測該使用者呼出氣體整體的二氧化碳濃度作為血糖濃度評估的依據時,該使用者最先呼出的氣體中還包含有來自口腔、呼吸道及支氣管等無效腔氣體,且該等無效腔氣體因未在肺部與血液進行呼吸交換,因此會影響到二氧化碳濃度量測的準確度,故本發明透過僅量測使用者於呼氣過程的末段呼氣量的二氧化碳濃度,由於該末段呼氣量為該使用者在整個呼氣過程的最後呼出的氣體,因此可避免因為該等無效腔氣體對二氧化碳濃度量測的干擾,而可提升二氧化碳濃度量測的準確性,以增進血糖評估的準確性。要說明的是,該總呼氣量(相當於肺活量)依據不同的年齡、生理狀況等都會有所不同,該末段呼氣量均是以實質不大於總呼氣量的10%為基礎。 Since the measurement of the overall carbon dioxide concentration of the user's exhaled gas is used as the basis for evaluating the blood glucose concentration, the first exhaled gas of the user also contains dead space gas from the oral cavity, respiratory tract and bronchi, and the dead space gas Because there is no respiratory exchange between the lungs and the blood, the accuracy of carbon dioxide concentration measurement will be affected. Therefore, the present invention only measures the carbon dioxide concentration of the user's expiratory volume at the end of the exhalation process. The expiratory volume is the gas that the user exhales at the end of the entire exhalation process, so it can avoid the interference of the dead space gas on the carbon dioxide concentration measurement, and can improve the accuracy of the carbon dioxide concentration measurement to improve the blood sugar assessment. accuracy. It should be noted that the total expiratory volume (equivalent to vital capacity) will vary according to different ages, physiological conditions, etc., and the final expiratory volume is based on the fact that the essence is not greater than 10% of the total expiratory volume.
前述該第一實施例是利用於呼氣過程中持續量測使用者呼出氣體之二氧化碳的依時濃度結果,再利用擷取該末段呼氣時間區間的二氧化碳濃度進行血糖值的評估。然,實際實施時,也可以無須持續量測呼出氣體之二氧化碳的濃度,而是可依據量測前的數 據評估結果,而僅量測使用者於該末段呼氣時間區間的二氧化碳的濃度,同樣可達成本發明之目的。茲將該方法以下述第二實施例說明。 The aforementioned first embodiment utilizes the time-dependent concentration result of continuously measuring the carbon dioxide in the user's exhaled breath during the exhalation process, and then uses the captured carbon dioxide concentration in the final exhalation time interval to evaluate the blood glucose level. Of course, in actual implementation, it is not necessary to continuously measure the concentration of carbon dioxide in the exhaled breath, but can be based on the data before the measurement. According to the evaluation result, only measuring the concentration of carbon dioxide in the end exhalation time interval of the user can also achieve the purpose of the present invention. This method will be illustrated in the following second embodiment.
參閱圖1、圖4,本發明血糖濃度評估方法的該第二實施例包含一預評估步驟60、該呼氣擷取量測步驟61,及該血糖評估步驟62。
Referring to FIG. 1 and FIG. 4 , the second embodiment of the blood glucose concentration assessment method of the present invention includes a
該預評估步驟60是利用該檢測裝置200擷取該使用者於前次的一連續時間區間T0~Tn呼出的呼氣氣體,並經由該分析單元5進行時間積分計算,以得到該使用者在該連續時間區間T0~Tn的總呼氣量及/或依時氣體流量,透過該總呼氣量計算得到末段呼氣量,並利用該末段呼氣量得到相應的一末段呼氣時間區間,而取得該末段呼氣時間區間的一預設起始擷取時間,及一預設結束擷取時間。
In the
接著,執行該呼氣擷取量測步驟61,與該第一實施例不同的是,由於該預評估步驟60已預估該使用者之末段呼氣時間區間的該預設起始擷取時間及該預設結束擷取時間,因此,該第二實施例的氣體擷取量測步驟61是將自該預評估步驟60所定義出的該預設起始擷取時間及該預設結束擷取時間作為當次量測之該末段呼氣量的該起始擷取時間TX1,及該結束擷取時間TX2,而僅須測量該使用者在當次的整個呼氣過程中,TX1~TX2的時間區間內的二氧
化碳濃度即可,而無須持續量測該使用者於整個呼氣過程中呼出氣體之二氧化碳濃度。最後,即可透過該血糖評估步驟62利用量測得到的該末段呼氣時間區間的二氧化碳濃度與相應的標準血糖值進行比對,得到血糖評估結果。
Next, the expiratory
在一些實施例中,該預評估步驟60,也可以無須實際進行量測,而是透過一總呼氣量預設值及一呼氣時間預定值計算而得到該預設起始擷取時間與該預設結束擷取時間,其中,該總呼氣量預設值與該呼氣時間預定值是依據該使用者的年齡、性別或其他生理特徵的其中一種,或是現有的資料庫而設定。
In some embodiments, in the
本案之檢測方法可通過觀察該使用者分別在不同時間點所測得該末段呼氣的二氧化碳濃度的整體變化趨勢,來評估該使用者的血糖狀況,例如:當該使用者在進食後,其末段呼氣的二氧化碳濃度隨著時間持續增加,且過了約2小時後尚無減低的跡象,表示該使用者的血糖濃度很高,可能有糖代謝能力不足的問題。 The detection method in this case can evaluate the user's blood sugar status by observing the overall change trend of the end-expiratory carbon dioxide concentration measured by the user at different time points. The carbon dioxide concentration in the final exhalation continued to increase with time, and there was no sign of decrease after about 2 hours, indicating that the user's blood sugar concentration was very high, and there may be a problem of insufficient glucose metabolism.
參閱圖3,該末段呼氣的二氧化碳濃度與血糖濃度值的關係曲線,可藉由令使用者進行糖耐受性測試(Oral glucose tolerance test,OGTT)而得。首先,令該使用者於空腹的情況下服用75克的葡萄糖(glucose);接著,在120分鐘內讓該使用者每間隔30分鐘利用該檢測裝置200來測量該末段呼氣的二氧化碳濃度,並同時量測該使用者的血糖濃度值(見表1)。圖3為該使用者進
行糖耐受性測試,於進食葡萄糖前、後不同時間點所測得的該末段呼氣時間區間的二氧化碳濃度(實線),及自身的血糖濃度值(虛線)。自圖3中可以發現,該末段呼氣時間區間的二氧化碳濃度與血糖濃度值二者成正向相關。因此,透過該末段呼氣的二氧化碳濃度與該使用者的血糖濃度值的量測結果,即可建立該末段呼氣的二氧化碳濃度與血糖濃度值的關係曲線。後續以本發明之檢測方法量得的二氧化碳濃度即可透過內插法取得對應的血糖濃度值,最後,再將該血糖濃度值與一標準血糖濃度值進行比對,即可得到血糖評估結果,例如,一般使用者進食約120分鐘後,標準血糖濃度值應不大於200mg/dL。若該使用者進食約120分鐘後,由本發明測得之該末段呼氣的二氧化碳濃度推算出的血糖濃度值為210mg/dL,與該標準血糖濃度值比對後為超出,則顯示該使用者可能有糖代謝能力不足的問題,應盡速至醫療院所就醫診察。此外,要說明的是,該二氧化碳濃度與血糖濃度值之間的對應關係也可以是取自現有的資料庫。
Referring to FIG. 3 , the relationship between the carbon dioxide concentration and the blood glucose concentration value in the final exhalation can be obtained by allowing the user to perform an Oral glucose tolerance test (OGTT). First, make the user take 75 grams of glucose on an empty stomach; then, within 120 minutes, let the user use the
綜上所述,本發明血糖濃度的評估方法通過該呼氣擷取
步驟61將自該呼氣氣體中擷取出該末段呼氣以進行二氧化碳濃度的量測來進行血糖評估,排除來自口腔、呼吸道或支氣管等無效腔氣體的干擾,進而提升血糖濃度之評估的準確性,此外,該檢測裝置200可供該使用者以非侵入性的方式進行血糖評估且檢測流程簡單,更有利於血糖評估的進行,故確實能達成本發明的目的。
To sum up, the method for evaluating blood glucose concentration of the present invention uses the breath capture
In
惟以上所述者,僅為本發明的實施例而已,當不能以此限定本發明實施的範圍,凡是依本發明申請專利範圍及專利說明書內容所作的簡單的等效變化與修飾,皆仍屬本發明專利涵蓋的範圍內。 However, the above are only examples of the present invention, and should not limit the scope of implementation of the present invention. Any simple equivalent changes and modifications made according to the scope of the patent application of the present invention and the contents of the patent specification are still included in the scope of the present invention. within the scope of the invention patent.
61:呼氣擷取量測步驟 61: Exhalation capture measurement steps
62:血糖評估步驟 62: Blood Glucose Assessment Steps
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110112767A TWI766640B (en) | 2021-04-08 | 2021-04-08 | Evaluation method and detection device for blood glucose concentration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110112767A TWI766640B (en) | 2021-04-08 | 2021-04-08 | Evaluation method and detection device for blood glucose concentration |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI766640B true TWI766640B (en) | 2022-06-01 |
TW202239374A TW202239374A (en) | 2022-10-16 |
Family
ID=83103642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110112767A TWI766640B (en) | 2021-04-08 | 2021-04-08 | Evaluation method and detection device for blood glucose concentration |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI766640B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI319978B (en) * | 2006-09-19 | 2010-02-01 | ||
TWI510217B (en) * | 2010-11-08 | 2015-12-01 | Univ Nat Kaohsiung Applied Sci | Non-invasive blood glucose value multi-measuring method and a device thereof |
TW201621316A (en) * | 2014-11-07 | 2016-06-16 | Toppan Printing Co Ltd | Method and device for measuring blood glucose level |
-
2021
- 2021-04-08 TW TW110112767A patent/TWI766640B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI319978B (en) * | 2006-09-19 | 2010-02-01 | ||
TWI510217B (en) * | 2010-11-08 | 2015-12-01 | Univ Nat Kaohsiung Applied Sci | Non-invasive blood glucose value multi-measuring method and a device thereof |
TW201621316A (en) * | 2014-11-07 | 2016-06-16 | Toppan Printing Co Ltd | Method and device for measuring blood glucose level |
Also Published As
Publication number | Publication date |
---|---|
TW202239374A (en) | 2022-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230320660A1 (en) | Devices and methods for monitoring physiologic parameters | |
JP6424172B2 (en) | Breathing selection for analysis | |
US20210236004A1 (en) | Devices and methods for monitoring physiologic parameters | |
RU2621393C2 (en) | Automated spirogram analysis and interpretation | |
US9532731B2 (en) | Method and apparatus for measuring the concentration of a gas in exhaled air | |
EP2536333A1 (en) | Nitric oxide measurement method and apparatus | |
EP1632178A1 (en) | Method for non-cooperative lung function diagnosis using ultrasound | |
WO2019152699A1 (en) | Devices and methods for monitoring physiologic parameters | |
WO2023046169A1 (en) | Alveolar gas concentration measurement apparatus and method for separated airway | |
JP2023518805A (en) | Devices for predicting, identifying and/or managing pneumonia or other medical conditions | |
AU2020417750A1 (en) | Breath sensor measurement methods and apparatus | |
TWI766640B (en) | Evaluation method and detection device for blood glucose concentration | |
Voter et al. | Pulmonary function testing in childhood asthma | |
WO2006068622A1 (en) | System and method for detecting of pulmonary diseases | |
CN109316189B (en) | Non-contact respiration dynamic detection method and device | |
Khodaie et al. | Design and Implementation of an Apparatus for Respiratory Parameters Estimation Based on Acoustic Methods | |
CN217237937U (en) | Alveolar gas concentration detection device for separating air passage | |
CN117770792A (en) | Method and system for measuring concentration of nitric oxide in non-respiratory tract | |
CN117770793A (en) | Gas signal molecule expiration detection method, system and electronic equipment | |
Hull et al. | Pulmonary function and exercise testing | |
Micski | CO2 Flow Estimation using Sidestream Capnography and Patient Flow in Anaesthesia Delivery Systems | |
Sarangi et al. | Pulmonary Function Tests and Their Clinical Applications | |
CN117770794A (en) | Device and method for jointly measuring nasal resistance and nasal exhalation nitric oxide concentration | |
Scanlan et al. | Pulmonary Function Testing | |
Sumer | Pulmonary function tests in clinical practice: Importance, requirements and limitations |